We have investigated the ability of cells derived from the human joint to generate nitric oxide (NO). Synovial fibroblasts, articular chondrocytes and osteoblasts were cultured from tissues of patients undergoing hip replacement surgery, and synovial fluid leucocytes were obtained from patients undergoing joint aspiration. There was little spontaneous generation of NO by any of the cells after culture, but synovial fibroblasts, articular chondrocytes and osteoblasts all produced large quantities of NO in response to a cytokine mix of interleulrin (JL)-\p + tumour necrosis factor o (TNFa) + interferon (IFNy). Reverse transcription-polymerase chain reaction (RT-PCR) analysis showed the presence of mRNA transcripts for the inducible isoform of NO synthase in cytokine-stimulated but not in unstimulated cells. In contrast, leucocytes from synovial fluid did not produce NO either spontaneously or after cytokine stimulation, and mRNA for inducible NO synthase (iNOS) was not detected in these cells even by nested PCR. There were significant differences in the regulation of NO production between chondrocytes and other cells. Only chondrocytes generated NO in response to IL-1/? or TNFa alone, whereas synovial fibroblasts and osteoblasts required the presence of at least two cytokines to generate NO. Dexamethasone (10"' M) had a small but significant inhibitory effect on NO production by chondrocytes, synovial fibroblasts and osteoblasts. Our results indicate that several cells within the human joint have the potential to generate NO in the presence of an appropriate pro-inflammatory cytokine stimulus, while leucocytes in synovial fluid are not a significant source of NO. The data support suggestions that NO is produced within the inflamed joint in diseases such as rheumatoid arthritis.
Nrnuc oxide (NO) is a short-lived free radical with important roles in a number of biological processes [1, 2] . In mammalian vascular endothelium and nervous tissue, NO is produced by two distinct calrium/calmodulin-dependent forms of NO synthase, where it acts respectively as a mediator of smooth muscle relaxation and of neurotransmission via stimulation of cyclic guanosine monophosphate (cGMP) production [1] . Many other mammalian cells, including macrophages [3] , neutrophils [4] , lymphocytes [5] , mesangial cells [6] , hepatocytes [7] and bone marrow cells [8] , can be induced to generate NO when exposed to bacterial endotoxin or inflammatory cytokines such as interleukin 1 (IL-1), tumour necrosis factor (TNF) and interferon gamma (IFNy), through a third distinct NO synthase isoform. This cytokineinducible NO synthase has been implicated in immunoregulation and host defence mechanisms [3, 5] .
Recent evidence, much of which is derived from animal experiments, suggests that NO may act as a pro-inflammatory mediator in inflammatory joint disease. Inhibitors of NO synthesis have markedly altered the progression of joint destruction and inflammatory processes in animal models of arthritis [9] [10] [11] . In man, concentrations of the NO metabolite, nitrite, have been shown to be greater in serum and synovial fluid from patients with rheumatoid arthritis and osteoarthritis than in age-and sex-matched controls [12] . Since nitrite levels in synovial fluid in these patients were found to be greater than those in serum, it has been suggested that NO is produced within the inflamed joint. Experiments in vitro have identified chondrocytes in man [13] and rabbits [14] , and synovial fibroblasts in rabbits [15] , as sources of NO when stimulated with pro-inflammatory cytokines and bacterial endotoxin. We have also recently shown that human osteoblast-like cells produce NO in culture in response to cytokines [16] .
Since there is little information on sources of NO production in human joint-derived cells, we have compared the ability of different cells derived from the joint to generate NO in vitro. We demonstrate differential regulation of NO production in human chondrocytes compared with osteoblasts or synovial fibroblasts, while showing that leucocytes from synovial fluid aspirates do not produce NO either spontaneously or in response to cytokine stimulation.
MATERIALS AND METHODS

Patients and tissues
Human femoral heads and synovial tissues from five patients with osteoarthritis and from four patients with rheumatoid arthritis were collected into sterile phosphate-buffered saline (PBS) during joint replacement surgery and transported to the laboratory within 2 h of operation.
Reagents and materials
Collagenase (type I and type IV) and deoxyribonuclease I (DNase) were obtained from Sigma Chemical Co. (Poole, UK). Dulbecco's Minimal Essential Medium (DMEM), Basal Medium with Earle's salts (BME), Hanks Balanced Salt Solution (HBSS), fetal calf serum (FCS), L-glutamine, penicillin, streptomycin and trypsin were purchased from Gibco (Paisley). Tissue culture plastics (90 mm 2 flasks, 90 mm plates, 6-and 96-well plates) were purchased from Costar (Cambridge, MA, USA).
Human recombinant IL-1/?, human recombinant TNFa and human recombinant IFNy were obtained from Boehringer Mannheim (Lewes, UK). L-N°-Monomethyl arginine (L-NMMA) and dexamethasone were obtained from Sigma Chemical Co. (Poole). Cytokines were diluted in culture medium immediately before use from concentrated stock solutions (prepared in culture medium with 5% heat-inactivated FCS and stored at -20°C in single-use aliquots). L-NMMA was added from a concentrated stock solution (5 x 10"* M) prepared in PBS at -20°C. Dexamethasone was diluted from a stock solution in ethanol.
Osteoblasts
Osteoblasts were prepared and cultured as previously described [16] . Briefly, trabecular bone chips were washed in PBS and adherent cells were removed from the bone surface by digestion in collagenase. Chips were placed in 90 mm plates in DMEM supplemented with 10% FCS, glutamine (2 x 10~3 M), penicillin (50 IU/ml) and streptomycin (50 /ig/ml), and the medium was changed twice weekly until a confluent layer of osteoblast-like cells was obtained (typically 3-5 weeks). These cells exhibited osteoblast characteristics at confluence, including increased alkaline phosphatase activity after 48-72 h of treatment with 1,25-dihydroxy-vitamin D 3 (10~'M), and expressed type I collagen and osteocalcin mRNAs detected by reverse transcription-polymerase chain reaction (RT-PCR; data not shown).
Chondrocytes
Chondrocytes were isolated as described by Palmer et at. [13] . Cells were grown to confluence in BME supplemented with 10% FCS, glutamine (2 x 10"' M), penicillin (50 IU/ml) and streptomycin (50 ^g/ml), with medium changes every 3-4 days. At confluence, these cells exhibited a 'cobblestone' appearance, secreted matrix and expressed type II collagen mRNA detected by RT-PCR (data not shown).
Synovia! fibroblasts
Synovial fibroblasts were prepared by the method of Dayer et al. [17] . Briefly, synovium was digested serially with a collagenase/DNase mixture and trypsin, and the fibroblasts were selected by adhesion to tissue culture plastics. Cells were grown to confluence in DMEM supplemented with 10% FCS, glutamine (2 x 10~3 M), penicillin (50 IU/ml) and streptomycin (50 ^g/ml), and were passaged up to two times, with medium changes every 3-4 days. At confluence, these cells exhibited a varied fibroblast morphology ranging from small round cells to large cells with multiple processes. Collagenase activity was detectable using zymography (data not shown) following culture in serum-free medium, in keeping with the description of these cells by Dayer et al. [17] .
Synovial leucocytes
Synovial fluid was obtained from routine knee aspirations of eight patients into tubes containing 0.5 ml ethylenediaminetetraacetic acid (2 mg/ml) as anticoagulant. The cellular fraction was separated by centrifugation, washed thoroughly in PBS and placed in DMEM supplemented with 10% FCS, glutamine (2 x 10"' M), penicillin (50 IU/ml) and streptomycin (50 /ig/ml) at a density of 10* cells/ml. Cells were used immediately after harvesting.
Nitric oxide production
Nitric oxide production was assessed by measurement of a stable NO metabolite, nitrite, in a microtitre plate adaptation of the Griess assay as previously described [18] . We have demonstrated elsewhere [16] that nitrite measured in the growth medium reflects a constant proportion of total NO production by cells in culture. Concentrations of nitrite in conditioned media were calculated with reference to standards of sodium nitrite in fresh culture medium.
Experimental cultures
Osteoblasts, synovial fibroblasts and chondrocytes were harvested from confluent cultures by incubation with trypsin. In most experiments, cells were plated out at a density of 0.5 x 10 5 cells/well in 96-well tissue culture plates in 200 n\ culture medium and allowed to adhere for 24 h. Synovial leucocytes were plated out at a density of 1 x 10 3 cells/well and studied without pre-incubation. In all experiments, at least four replicates for each treatment were set up. Cytokines and drugs were added to experiments in fresh culture medium, and all experimental wells were adjusted to a final volume of 250 fil. Control experiments contained medium alone or an equivalent amount of vehicle in medium where appropriate. Cells were incubated for 48 h at 37°C, at which time experiments were terminated. Plates were centrifuged for 5 min at 800 g, and 200 //I of the medium from each well were transferred to a fresh microtitre plate and assayed for nitrite.
Molecular biology
RT-PCR was performed with total RNA from some cultures to identify which isoform of NO synthase was expressed. In these experiments, cultures were set up in duplicate in 6-well plates at a density of 3 x 10* cells/well in 3 ml culture medium. Synovial fibroblasts, osteoblasts and chondrocytes were allowed to adhere for 24 h prior to incubation with cytokines and other reagents for a further 24 h. Synovial leucocytes were used immediately after harvesting or following a 24 h incubation in the presence or absence of cytokines. Aliquots (200 fi\) of conditioned media were assayed for nitrite and the remaining medium was aspirated. Total RNA was extracted from cells by the method of Chomczynski and Sacchi [19] , and quantified by spectrometry. RT-PCR was performed as previously described for 35 cycles using oligonucleotide primers recognizing motifs in mammalian NO synthase isoforms which are conserved across species [16] . The identities of products from PCR were confirmed by direct sequencing on an ABI373 sequencer. Nucleotide sequences were compared with those held in the GenBank database [20] .
Statistical analysis
Results shown in the figures are taken from typical representative experiments, and displayed as means + S.D. for four replicates. Individual experiments were analysed by one-way ANOVA, and Tukey's test or Dunnett's test were employed where appropriate to determine significance between treatments.
RESULTS
Basal and cytokine-stimulated NO production by synovial fibroblasts, osteoblasts and chondrocytes from typical experiments are shown in Fig. 1 spontaneously generated NO, measured as nitrite released into culture medium. The amount of nitrite measured in unstimulated experiments was not significantly different from that measured in culture medium incubated over the same period of time in the absence of cells (Fig. 1A ) and was typically < 1.5 nmol/10 3 cells over 48 h. There was little or no production of NO by synovial fibroblasts or osteoblasts in response to any of IL-l/J, TNFa or IFNy at the concentrations shown (Fig. 1A) , or at higher concentrations up to 100 U/ml IL1-/J, lOOng/ml TNFa or 1000 U/ml IFNy (data not shown). In contrast, chondrocytes generated small but significant quantities of NO in response to IL-1/? or TNFa alone, but not IFNy (Fig. 1A) . NO production by chondrocytes in response to these cytokines was dose dependent (data not shown).
Synovial fibroblasts, osteoblasts and chondrocytes all generated significant quantities of NO in response to combinations of two cytokines (Fig. IB) , but chondrocytes and synovial fibroblasts generally produced more NO than osteoblasts for any cytokine combination.
Synovial fibroblasts, osteoblasts and chondrocytes produced substantial quantities of NO when stimulated with a combination of pro-inflammatory cytokines (Fig. IB) consisting of IL-10 (10 U/ml) + TNFa (25 ng/ml) + IFNy (100 U/ml). In contrast, synovial leucocytes failed to generate NO in response to individual cytokines or to the combination of all three cytokines (data not shown). NO production by synovial fibroblasts, osteoblasts and chondrocytes occurred at similar rates, ranging from ~ 5 to 20 nmol of nitrite/10 3 cells over 48 h. Production of NO by synovial fibroblasts, chondrocytes and osteoblasts was significantly inhibited to <35% of cytokine-stimulated levels in all experiments in the presence of the competitive inhibitor of NO synthase, L-NMMA, at a concentration of 10~4 M (Fig. 2) . Dexamethasone at a concentration of 10" 6 M produced a small but significant inhibition of cytokine-stimulated NO production by synovial fibroblasts, osteoblasts and chondrocytes (Fig. 2) . The mean inhibition ranged from 8 to 28% with synovial fibroblasts (three experiments), from 15 to 35% with osteoblasts (four experiments), and from 5 to 18% with chondrocytes (three experiments).
We characterized the type of NO synthase present in cell cultures by RT-PCR using degenerate oligonucleotide primers which generate characteristic products for inducible and constitutive NO synthase isoforms [16] . A 490 bp product was detected in the cytokine-stimulated cultures of osteoblasts, synovial fibroblasts and chondrocytes which produced NO. This corresponded to the predicted product size for inducible NO synthase (iNOS). When directly sequenced, all the PCR products were identical to the published sequence for human iNOS [21] . There was no evidence of a 610 bp product corresponding to neuronal or endothelial isoforms of NO synthase. In unstimulated cultures of osteoblasts, synovial fibro- blasts or chondrocytes, the 490 bp product was barely or not detected. mRNA for iNOS was also detected in cytokine-stimulated cultures of synovial fibroblasts and osteoblasts and chondrocytes in the presence of dexamethasone (10~6 M), where NO production was significantly inhibited. Products from a typical RT-PCR using RNA from chondrocytes are shown in Fig. 3 . NO synthase PCR products were not detected in unstimulated or cytokine-stimulated synovial leucocytes from eight patients with rheumatoid arthritis, even when using a nested PCR (data not shown).
DISCUSSION
Recent studies have indicated that NO may be an important mediator in inflammatory joint disease, since competitive inhibitors of NO synthase suppress the inflammation and tissue damage in animal models of arthritis [9] [10] [11] . A number of sources of NO within the inflamed joint have been suggested, including chondrocytes [13, 14] and synovial fibroblasts [15] , but little is known about the relative contribution of these and other cells to NO production in man. The aim of this study was to identify sources of NO in the human joint.
The data presented in this paper demonstrate that a variety of cells within the human joint have the potential to generate NO when stimulated with inflammatory cytokines which are known to be present in the inflamed joint in diseases such as rheumatoid arthritis. Using primary cultures of cells we have shown that osteoblasts, synovial fibroblasts and chondrocytes generated little or no NO spontaneously after growing in culture, but these cells produced substantial quantities of NO in the presence of a combined cytokine stimulus consisting of ILIfi + TNFa + IFNy. As expected, NO production was inhibited in all three cell types by L-NMMA, a competitive inhibitor of the NO synthases. Analysis of the nucleotide sequences of PCR products, amplified using degenerate NO synthase oligonudeotide primers, indicated that mRNA for inducibie rather than endothelial or neuronal NO synthase was expressed in all three cell types which produced NO in response to the cocktail of pro-inflammatory cytokines.
Combinations of any two cytokines induced modest but significant quantities of NO in osteoblasts, synovial fibroblasts and chondrocytes. In contrast, only chondrocytes generated significant quantities of NO in response to either IL-1/? or TNFa alone. The results of our experiments support previous studies using a variety of human and animal cells, which demonstrate that single cytokines are less effective inducers of NO than combinations of cytokines [1, 2, [6] [7] [8] 16] .
We have confirmed previous observations that human chondrocytes generate NO in response to single cytokine stimuli [13] , while other cells such as osteoblasts and synovial fibroblasts require multiple cytokine stimuli to generate substantial quantities of NO. This observation suggests that chondrocytes must either utilize an alternative cytokine signalling pathway to that used by osteoblasts or synovial fibroblasts, or that they may invoke different regulators in the transcriptional activation or post-transcriptional processing of the inducibie NO synthase gene.
In contrast to the tissue-derived cells, the synovial fluid-derived cells failed to produce NO either spontaneously or in response to stimulation by pro-inflammatory cytokines. This observation was strengthened by our failure to detect mRNA for iNOS in freshly isolated cells, even in a nested RT-PCR. These cells are largely (~85%) polymorphonuclear leucocytes, and the remainder of the cells are lymphocytes with a small proportion (1-2%) of macrophages. In rodents, phagocytic cells such as macrophages generate NO abundantly in response to cytokines and lipopolysaccharide [3] . However, our results are consistent with other reports that NO production is not readily induced by cytokines in human phagocytic cells [22] .
NO has a short half-life and its actions are thought to be confined to within a few cells' distance of its source of production [23] . Farrell et al. [12] suggest that NO is generated within the joint in inflammatory diseases such as rheumatoid arthritis. The role of NO in inflammatory joint diseases is not clear. NO may contribute to inflammation through its vasodilatory actions. It can react with superoxide radicals to form peroxynitrite, which is highly toxic and decomposes readily to form an oxidant with hydroxyl radical reactivity and nitrogen dioxide [24] . Recent evidence indicates that NO is involved in specific processes within skeletal tissues such as bone and cartilage. We have demonstrated that NO contributes to IL-1-induced bone resorption in mouse calvariae [25] , while Taskiran et al. [26] have shown that NO mediates suppression of proteoglycan synthesis by IL-1 in rabbit articular cartilage explants.
It is not known which cells within the joint generate NO in vivo. In these experiments, we were unable to conclude whether any of the cells studied were actively producing NO at the time of biopsy, since the procedures used to isolate the cells from joint-derived tissues involved digestion with enzymes derived from bacteria, which potentially contain contaminating products that may in themselves induce NO synthase activity. Nonetheless, our results confirm that there are a number of potential cellular sources of NO. Our studies have demonstrated differences in the regulation of NO production between cells, but it is difficult to speculate on the relative importance of these cells in the production of NO in vivo since induction of NO synthase in any cell will depend not only on which stimulatory signals are present in the local extracellular milieu, but also on the presence or absence of inhibitory factors. To answer the question of which cells produce NO in vivo, we are currently investigating the expression of NO synthase directly in joint-derived tissues by immunohistochemistry and in situ hybridization.
We have also demonstrated that NO production in human joint-derived cells is relatively insensitive to inhibition by dexamethasone. Palmer et al. [13] previously showed that dexamethasone at 10"' or 10"'M inhibited NO production in human articular chondrocytes to a small degree. Similarly, in our experiments, the inhibition of NO production with dexamethasone (10"'M) was not extensive in synovial fibroblasts or chondrocytes, and only reached > 30% in some experiments with osteoblasts. This contrasts with the situation in vascular endothelial cells where inducible NO production is almost abolished by dexamethasone [27] . These results may have implications for the treatment of diseases such as rheumatoid arthritis where glucocorticoids are widely used to suppress inflammation, and to reduce joint erosions [28] . Inhibitors of NO synthesis have recently been used successfully to prevent or reverse joint destruction in animal models of arthritis [9] [10] [11] , and the development of novel therapeutic strategies involving suppression of NO production may prove to be beneficial in inflammatory joint diseases in the future.
